A Comprehensive Study to Investigate the Tumor-Suppressive Role of Radix Bupleuri on Gastric Cancer with Network Pharmacology and Molecular Docking

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Wang J, Wang Y, Wang J, et al. DEAD-box helicase 56 functions as an oncogene promote cell proliferation and invasion in gastric cancer via the FOXO1/p21 Cip1/c-Myc signaling pathway. Bioengineered. 2022;13(5):13970–13985. doi:10.1080/21655979.2022.2084235
   PubMed Web of Science ®Google Scholar
• Zhang T, Chen H, Yin X, et al. Changing trends of disease burden of gastric cancer in China from 1990 to 2019 and its predictions: findings from global burden of disease study. Chin J Cancer Res. 2021;33(1):11–26. doi:10.21147/j.issn.1000-9604.2021.01.02
   PubMed Web of Science ®Google Scholar
• Machlowska J, Kapusta P, Baj J, et al. High-throughput sequencing of gastric cancer patients: unravelling genetic predispositions towards an early-onset subtype. Cancers. 2020;12(7):1981. doi:10.3390/cancers12071981
   PubMed Web of Science ®Google Scholar
• Gao C, Liu F, Ye Q, Guo A. Cancer-associated fibroblasts affect tumor metabolism and immune microenvironment in gastric cancer and identification of its characteristic genes. J Oncol. 2023;2023:1424589. doi:10.1155/2023/1424589
   PubMedGoogle Scholar
• Le X, Mu J, Peng W, et al. DNA methylation downregulated ZDHHC1 suppresses tumor growth by altering cellular metabolism and inducing oxidative/ER stress-mediated apoptosis and pyroptosis. Theranostics. 2020;10(21):9495–9511. doi:10.7150/thno.45631
   PubMed Web of Science ®Google Scholar
• Huang Z, Wei P. Compound Kushen Injection for gastric cancer: a protocol of systematic review and meta-analysis. Medicine. 2019;98(45):e17927. doi:10.1097/MD.0000000000017927
   PubMed Web of Science ®Google Scholar
• Song S, Zhou J, Li Y, Liu J, Li J, Shu P. Network pharmacology and experimental verification based research into the effect and mechanism of aucklandiae radix-amomi fructus against gastric cancer. Sci Rep. 2022;12(1):9401. doi:10.1038/s41598-022-13223-z
   PubMed Web of Science ®Google Scholar
• Li X, Li X, Huang N, Liu R, Sun R. A comprehensive review and perspectives on pharmacology and toxicology of saikosaponins. Phytomedicine. 2018;50:73–87. doi:10.1016/j.phymed.2018.09.174
   PubMed Web of Science ®Google Scholar
• Yan LJ, Wang ZJ, Fang M, et al. Bupleuri radix for acute uncomplicated respiratory tract infection: a systematic review of randomized controlled trials. Front Pharmacol. 2022;12:787084. doi:10.3389/fphar.2021.787084
   PubMed Web of Science ®Google Scholar
• Chen Y, Wang J, Yuan L, Zhou L, Jia X, Tan X. Interaction of the main components from the traditional Chinese drug pair Chaihu-Shaoyao based on rat intestinal absorption. Molecules. 2011;16(11):9600–9610. doi:10.3390/molecules16119600
   PubMed Web of Science ®Google Scholar
• Yang F, Dong X, Yin X, Wang W, You L, Ni J. Radix bupleuri: a review of traditional uses, botany, phytochemistry, pharmacology, and toxicology. Biomed Res Int. 2017;2017:7597596. doi:10.1155/2017/7597596
   PubMed Web of Science ®Google Scholar
• Wang J, Qi H, Zhang X, et al. Saikosaponin D from Radix Bupleuri suppresses triple-negative breast cancer cell growth by targeting β-catenin signaling. Biomed Pharmacother. 2018;108:724–733. doi:10.1016/j.biopha.2018.09.038
   PubMed Web of Science ®Google Scholar
• Cheng T, Ying M. Antitumor effect of saikosaponin A on human neuroblastoma cells. Biomed Res Int. 2021;2021:5845554. doi:10.1155/2021/5845554
   PubMed Web of Science ®Google Scholar
• Hu J, Li P, Shi B, Tie J. Effects and mechanisms of saikosaponin D improving the sensitivity of human gastric cancer cells to cisplatin. ACS Omega. 2021;6(29):18745–18755. doi:10.1021/acsomega.1c01795
   PubMed Web of Science ®Google Scholar
• Shang L, Wang Y, Li J, et al. Mechanism of Sijunzi Decoction in the treatment of colorectal cancer based on network pharmacology and experimental validation. J Ethnopharmacol. 2023;302(Pt A):115876. doi:10.1016/j.jep.2022.115876
   PubMedGoogle Scholar
• Liu J, Liu J, Tong X, et al. Network pharmacology prediction and molecular docking-based strategy to discover the potential pharmacological mechanism of Huai Hua San Against ulcerative colitis. Drug Des Devel Ther. 2021;15:3255–3276. doi:10.2147/DDDT.S319786
   PubMed Web of Science ®Google Scholar
• Gao J, Yang S, Xie G, Pan J, Zhu F. Integrating network pharmacology and experimental verification to explore the pharmacological mechanisms of aloin against gastric cancer. Drug Des Devel Ther. 2022;16:1947–1961. doi:10.2147/DDDT.S360790
   PubMed Web of Science ®Google Scholar
• Wang Y, Chu F, Lin J, et al. the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification. J Ethnopharmacol. 2021;279:114399. doi:10.1016/j.jep.2021.114399
   PubMed Web of Science ®Google Scholar
• Han L, Han Y. Network pharmacology-based study on the active component and mechanism of the anti-gastric-cancer effect of herba sarcandrae. J Healthc Eng. 2021;2021:3001131. doi:10.1155/2021/3001131
   PubMed Web of Science ®Google Scholar
• You M, Fu J, Lv X, Wang L, Wang H, Li R. Saikosaponin b2 inhibits tumor angiogenesis in liver cancer via down‑regulation of VEGF/ERK/HIF‑1α signaling. Oncol Rep. 2023;50(1):136. doi:10.3892/or.2023.8573
   PubMed Web of Science ®Google Scholar
• Ma Q, Gao FF, He X, et al. Antitumor effects of saikosaponin b2 on breast cancer cell proliferation and migration. Mol Med Rep. 2019;20(2):1943–1951. doi:10.3892/mmr.2019.10385
   PubMed Web of Science ®Google Scholar
• Shen X, Si Y, Wang Z, Wang J, Guo Y, Zhang X. Quercetin inhibits the growth of human gastric cancer stem cells by inducing mitochondrial-dependent apoptosis through the inhibition of PI3K/Akt signaling. Int J Mol Med. 2016;38(2):619–626. doi:10.3892/ijmm.2016.2625
   PubMed Web of Science ®Google Scholar
• Rong Y, Liu SH, Tang MZ, Yang XJ. Quercetin inhibits the proliferative effect of gastric cancer cells by activating the pyroptosis pathway. Asian J Surg. 2023;S1015–9584(23):1063.
   Google Scholar
• Yang L, Li H, Yang M, et al. Exploration in the mechanism of kaempferol for the treatment of gastric cancer based on network pharmacology. Biomed Res Int. 2020;2020:5891016. doi:10.1155/2020/5891016
   PubMed Web of Science ®Google Scholar
• Kim TW, Lee SY, Kim M, Cheon C, Ko SG. Kaempferol induces autophagic cell death via IRE1-JNK-CHOP pathway and inhibition of G9a in gastric cancer cells. Cell Death Dis. 2018;9(9):875. doi:10.1038/s41419-018-0930-1
   PubMed Web of Science ®Google Scholar
• Li Y, Fan B, Pu N, et al. Isorhamnetin suppresses human gastric cancer cell proliferation through mitochondria-dependent apoptosis. Molecules. 2022;27(16):5191. doi:10.3390/molecules27165191
   PubMed Web of Science ®Google Scholar
• Caner A, Asik E, Ozpolat B. SRC Signaling in Cancer and Tumor Microenvironment. Adv Exp Med Biol. 2021;1270:57–71.
   PubMed Web of Science ®Google Scholar
• Lee HW, Kim KM. Clinical significance of heat shock protein 90α expression as a biomarker of prognosis in patients with gastric cancer. Niger J Clin Pract. 2019;22(12):1698–1705. doi:10.4103/njcp.njcp_68_19
   PubMed Web of Science ®Google Scholar
• Deng T, Shen P, Li A, et al. CCDC65 as a new potential tumor suppressor induced by metformin inhibits activation of AKT1 via ubiquitination of ENO1 in gastric cancer. Theranostics. 2021;11(16):8112–8128. doi:10.7150/thno.54961
   PubMed Web of Science ®Google Scholar
• Liu HZ, Shan TD, Han Y, Liu XS. Silencing long non-coding RNA CASC9 inhibits colorectal cancer cell proliferation by acting as a competing endogenous RNA of miR-576-5p to regulate AKT3. Cell Death Discov. 2020;6(1):115. doi:10.1038/s41420-020-00352-5
   PubMed Web of Science ®Google Scholar
• Yu J, Feng H, Sang Q, et al. VPS35 promotes cell proliferation via EGFR recycling and enhances EGFR inhibitors response in gastric cancer. E Bio Medicine. 2023;89:104451.
   Google Scholar
• Higaki E, Kuwata T, Nagatsuma AK, et al. Gene copy number gain of EGFR is a poor prognostic biomarker in gastric cancer: evaluation of 855 patients with bright-field dual in situ hybridization (DISH) method. Gastric Cancer. 2016;19(1):63–73. doi:10.1007/s10120-014-0449-9
   PubMed Web of Science ®Google Scholar
• Fattahi S, Amjadi-Moheb F, Tabaripour R, Ashrafi GH, Akhavan-Niaki H. PI3K/AKT/mTOR signaling in gastric cancer: epigenetics and beyond. Life Sci. 2020;262:118513. doi:10.1016/j.lfs.2020.118513
   PubMed Web of Science ®Google Scholar
• Rong L, Li Z, Leng X, et al. Salidroside induces apoptosis and protective autophagy in human gastric cancer AGS cells through the PI3K/Akt/mTOR pathway. Biomed Pharmacother. 2020;122:109726. doi:10.1016/j.biopha.2019.109726
   PubMed Web of Science ®Google Scholar